ScinoPharm Taiwan, Ltd.

ScinoPharm Taiwan, Ltd. financial statements

ScinoPharm Taiwan, Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueTWD 3.16BEODHD
Net incomeTWD 136.95MEODHD
Cash and equivalentsTWD 3.11BEODHD
Total debtTWD 762.67MEODHD

ScinoPharm Taiwan, Ltd. financials on 6ix · ScinoPharm Taiwan, Ltd. on 6ix